Timothy Coughlin

Insider Reports History

Entity
Individual
Location
339 North Granados Ave, Solana Beach, CA
Signature
/s/ Cindy Tahl, as Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Timothy Coughlin:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Travere Therapeutics, Inc. Director Common Stock 49K $330K $6.74 May 8, 2024 Direct
FATE THERAPEUTICS INC Director Stock Option (Right to Buy) 40K $109K $2.73 Jun 7, 2024 Direct
aTYR PHARMA INC Director Common Stock 56K $98K $1.75 May 30, 2024 Indirect
aTYR PHARMA INC Director Stock Option (right to buy) 24K May 22, 2024 Direct
Travere Therapeutics, Inc. Director Stock option (right to buy) 19.5K May 8, 2024 Direct

Insider Reports Filed by Timothy Coughlin

Symbol Company Period Transactions Value $ Form Type Date Filed Role
FATE FATE THERAPEUTICS INC Jun 7, 2024 1 $0 4 Jun 11, 2024 Director
LIFE aTYR PHARMA INC May 30, 2024 1 $87.5K 4 Jun 3, 2024 Director
LIFE aTYR PHARMA INC May 22, 2024 1 $0 4 May 23, 2024 Director
TVTX Travere Therapeutics, Inc. May 8, 2024 2 $0 4 May 10, 2024 Director
FATE FATE THERAPEUTICS INC Jun 6, 2023 1 $0 4 Jun 7, 2023 Director
LIFE aTYR PHARMA INC May 17, 2023 3 $0 4 May 19, 2023 Director
TVTX Travere Therapeutics, Inc. May 17, 2023 2 $0 4 May 19, 2023 Director
LIFE aTYR PHARMA INC Apr 26, 2023 2 $0 4 Apr 28, 2023 Director
FATE FATE THERAPEUTICS INC Jun 9, 2022 2 $0 4 Jun 13, 2022 Director
FATE FATE THERAPEUTICS INC Jun 3, 2022 1 -$32.8K 4 Jun 6, 2022 Director
TVTX Travere Therapeutics, Inc. May 11, 2022 2 $0 4 May 12, 2022 Director
LIFE aTYR PHARMA INC Apr 26, 2022 1 $0 4 Apr 28, 2022 Director
FATE FATE THERAPEUTICS INC Jun 2, 2021 2 $0 4 Jun 4, 2021 Director
TVTX Travere Therapeutics, Inc. May 14, 2021 2 $0 4 May 18, 2021 Director